SUBSCRIBE TO TMCnet
TMCnet - World's Largest Communications and Technology Community

TMC NEWS

TMCNET eNEWSLETTER SIGNUP

Research and Markets: Acute Renal Failure (ARF) (Acute Kidney Injury) - Pipeline Review Report, H2 2013 Edition
[November 06, 2013]

Research and Markets: Acute Renal Failure (ARF) (Acute Kidney Injury) - Pipeline Review Report, H2 2013 Edition


DUBLIN --(Business Wire)--

Research and Markets (http://www.researchandmarkets.com/research/wz6dtl/acute_renal) has announced the addition of the "Acute Renal Failure (ARF) (Acute Kidney Injury) - Pipeline Review, H2 2013" report to their offering.

'Acute Renal Failure (ARF) (Acute Kidney Injury) - Pipeline Review, H2 2013', provides an overview of the indication's therapeutic pipeline. This report provides information on the therapeutic development for Acute Renal Failure (ARF) (Acute Kidney Injury), complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Acute Renal Failure (ARF) (Acute Kidney Injury).

Scope

  • A snapshot of the global therapeutic scenario for Acute Renal Failure (ARF) (Acute Kidney Injury).
  • A review of the Acute Renal Failure (ARF) (Acute Kidney Injury) products under development by companies and universities/research institutes based on information derived from company and industry-specific sources.
  • Coverage of products based on various stages of development ranging from discovery till registration stages.
  • A feature on pipeline projects on the basis of monotherapy and combined therapeutics.
  • Coverage of the Acute Renal Failure (ARF) (Acute Kidney Injury) pipeline on the basis of route of administration and molecule type.
  • Key discontinued pipeline projects.
  • Latest news and deals relating to the products.

Companies Mentioned


  • Quark Pharmaceuticals, Inc.
  • FibroGen, Inc.
  • Novartis AG
  • Hadasit Medical Research Services & Development Ltd
  • NephroGenex, Inc.
  • Torrent Pharmaceuticals Limited
  • Digna Biotech, S.L.
  • Am-Pharma B.V.
  • AlloCure Inc.
  • Angion Biomedica Corp.
  • Thrasos, Inc.
  • Bolder Biotechnology, Inc.
  • ChemoCentryx, Inc.
  • Kringle Pharma, Inc.
  • Nephrx Corporation
  • Cellmid Ltd
  • ACROVIS biostructures GmbH

For more information visit http://www.researchandmarkets.com/research/wz6dtl/acute_renal


[ Back To TMCnet.com's Homepage ]






Technology Marketing Corporation

35 Nutmeg Drive Suite 340, Trumbull, Connecticut 06611 USA
Ph: 800-243-6002, 203-852-6800
Fx: 203-866-3326

General comments: tmc@tmcnet.com.
Comments about this site: webmaster@tmcnet.com.

STAY CURRENT YOUR WAY

© 2018 Technology Marketing Corporation. All rights reserved | Privacy Policy